Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) Stock Short Interest Report for September

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) was the target of a large decrease in short interest in the month of September. As of September 30th, there was short interest totaling 67,129 shares, a decrease of 66.3% from the September 15th total of 199,073 shares. Based on an average daily trading volume, of 2,041,132 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.4% of the company’s stock are short sold.

Analyst Ratings Changes

Separately, Weiss Ratings lowered Hong Kong Pharma Digital Technology from a “sell (d)” rating to a “sell (e+)” rating in a research note on Thursday, August 13th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Hong Kong Pharma Digital Technology has an average rating of “Sell”.

Hong Kong Pharma Digital Technology Price Performance

HKPD stock traded down $0.01 during trading on Monday, hitting $0.10. 207,628 shares of the company’s stock traded hands, compared to its average volume of 1,374,354. The business has a fifty day simple moving average of $0.24 and a two-hundred day simple moving average of $0.42. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.75 and a current ratio of 3.86. Hong Kong Pharma Digital Technology has a 1 year low of $0.10 and a 1 year high of $1.72.

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) last posted its earnings results on Friday, August 7th. The company reported ($0.04) earnings per share for the quarter. The business had revenue of $3.15 million during the quarter.

Hong Kong Pharma Digital Technology Company Profile

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.